Propanc Biopharma, Inc. (PPCB) bonds
PPCBNasdaqPharmaceutical PreparationsFiscal year ends June 30
$1.92+0.08 (+4.35%)
Close on Nov 12, 2026Market cap $12.16MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Propanc Biopharma reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Propanc Biopharma's 10-K for the period ended Jun 30, 2025
| Issue | Coupon | Carrying value |
|---|---|---|
| Debt Placements | 6.00% | – |
| Equity And Equity Linked Placements | 8.00% | – |
| Promissory Note | – | $543.31K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?